• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

帕金森病中的皮质低代谢与胆碱能基底前脑萎缩有关。

Cortical hypometabolism in Parkinson's disease is linked to cholinergic basal forebrain atrophy.

作者信息

Labrador-Espinosa Miguel A, Silva-Rodriguez Jesús, Okkels Niels, Muñoz-Delgado Laura, Horsager Jacob, Castro-Labrador Sandra, Franco-Rosado Pablo, Castellano-Guerrero Ana María, Iglesias-Camacho Elena, San-Eufrasio Manuela, Macías-García Daniel, Jesús Silvia, Adarmes-Gómez Astrid, Ojeda-Lepe Elena, Carrillo Fátima, Martín-Rodríguez Juan Francisco, Roldan Lora Florinda, García-Solís David, Borghammer Per, Mir Pablo, Grothe Michel J

机构信息

Unidad de Trastornos del Movimiento, Servicio de Neurología y Neurofisiología Clínica, Instituto de Biomedicina de Sevilla, Hospital Universitario Virgen del Rocío/Universidad de Sevilla/CSIC/CIBERNED, Sevilla, Spain.

Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Instituto de Salud Carlos III, Madrid, Spain.

出版信息

Mol Psychiatry. 2025 Jun;30(6):2372-2380. doi: 10.1038/s41380-024-02842-9. Epub 2024 Dec 5.

DOI:10.1038/s41380-024-02842-9
PMID:39639173
Abstract

Cortical hypometabolism on FDG-PET is a well-established neuroimaging biomarker of cognitive impairment in Parkinson's disease (PD), but its pathophysiologic origins are incompletely understood. Cholinergic basal forebrain (cBF) degeneration is a prominent pathological feature of PD-related cognitive impairment and may contribute to cortical hypometabolism through cholinergic denervation of cortical projection areas. Here, we investigated in-vivo associations between subregional cBF volumes on 3T-MRI, cortical hypometabolism on [F]FDG-PET, and cognitive deficits in a cohort of 95 PD participants with varying degrees of cognitive impairment. We further assessed the spatial correspondence of the cortical pattern of cBF-associated hypometabolism with the pattern of cholinergic denervation in PD as assessed by [F]FEOBV-PET imaging of presynaptic cholinergic terminal density in a second cohort. Lower volume of the cortically-projecting posterior cBF, but not of the anterior cBF, was significantly associated with extensive neocortical hypometabolism [p(FDR) < 0.05], which mediated the association between cBF atrophy and cognitive impairment (mediated proportion: 43%, p < 0.001). In combined models, posterior cBF atrophy explained more variance in cortical hypometabolism (R = 0.26, p < 0.001) than local atrophy in the cortical areas themselves (R = 0.16, p = 0.01). Topographic correspondence analysis with the [F]FEOBV-PET pattern revealed that cortical areas showing most pronounced cBF-associated hypometabolism correspond to those showing most severe cholinergic denervation in PD (Spearman's ρ = 0.57, p < 0.001). In conclusion, posterior cBF atrophy in PD is selectively associated with hypometabolism in denervated cortical target areas, which mediates the effect of cBF atrophy on cognitive impairment. These data provide first-time in-vivo evidence that cholinergic degeneration represents a principle pathological correlate of cortical hypometabolism underlying cognitive impairment in PD.

摘要

氟代脱氧葡萄糖正电子发射断层扫描(FDG-PET)显示的皮质低代谢是帕金森病(PD)认知障碍中一种公认的神经影像学生物标志物,但其病理生理起源尚未完全明确。胆碱能基底前脑(cBF)变性是PD相关认知障碍的一个突出病理特征,可能通过皮质投射区域的胆碱能去神经支配导致皮质低代谢。在此,我们在95名不同程度认知障碍的PD参与者队列中,研究了3T磁共振成像(MRI)上cBF亚区域体积、[F]FDG-PET上的皮质低代谢与认知缺陷之间的体内关联。我们还在第二个队列中,通过对突触前胆碱能终末密度进行[F]FEOBV-PET成像,评估了PD中cBF相关低代谢的皮质模式与胆碱能去神经支配模式的空间对应关系。皮质投射的后cBF体积降低,而非前cBF体积降低,与广泛的新皮质低代谢显著相关[p(FDR)<0.05],这介导了cBF萎缩与认知障碍之间的关联(介导比例:43%,p<0.001)。在联合模型中,后cBF萎缩比皮质区域自身的局部萎缩能解释更多皮质低代谢的方差(R=0.26,p<0.001),而局部萎缩的解释力为(R=0.16,p=0.01)。与[F]FEOBV-PET模式的地形对应分析显示,PD中显示最明显cBF相关低代谢的皮质区域与显示最严重胆碱能去神经支配的区域相对应(斯皮尔曼ρ=0.57,p<0.001)。总之,PD中的后cBF萎缩与去神经支配的皮质靶区域低代谢选择性相关,这介导了cBF萎缩对认知障碍的影响。这些数据首次提供了体内证据,表明胆碱能变性是PD认知障碍潜在皮质低代谢的主要病理相关因素。

相似文献

1
Cortical hypometabolism in Parkinson's disease is linked to cholinergic basal forebrain atrophy.帕金森病中的皮质低代谢与胆碱能基底前脑萎缩有关。
Mol Psychiatry. 2025 Jun;30(6):2372-2380. doi: 10.1038/s41380-024-02842-9. Epub 2024 Dec 5.
2
Basal Forebrain Atrophy, Cortical Thinning, and Amyloid-β Status in Parkinson's disease-Related Cognitive Decline.基底前脑萎缩、皮质变薄与帕金森病相关认知衰退中的淀粉样β状态。
Mov Disord. 2023 Oct;38(10):1871-1880. doi: 10.1002/mds.29564. Epub 2023 Jul 26.
3
Parkinson's disease CA2-CA3 hippocampal atrophy is accompanied by increased cholinergic innervation in patients with normal cognition but not in patients with mild cognitive impairment.帕金森病患者认知正常但轻度认知障碍患者的 CA2-CA3 海马萎缩伴有胆碱能神经支配增加。
Brain Imaging Behav. 2024 Aug;18(4):783-793. doi: 10.1007/s11682-024-00872-z. Epub 2024 Mar 13.
4
Structural and molecular cholinergic imaging markers of cognitive decline in Parkinson's disease.帕金森病认知衰退的结构和分子胆碱能成像标志物。
Brain. 2023 Dec 1;146(12):4964-4973. doi: 10.1093/brain/awad226.
5
Grey matter hypometabolism and atrophy in Parkinson's disease with cognitive impairment: a two-step process.帕金森病伴认知障碍患者脑灰质代谢减少和萎缩:两步过程。
Brain. 2014 Aug;137(Pt 8):2356-67. doi: 10.1093/brain/awu159. Epub 2014 Jun 20.
6
Cholinergic basal forebrain atrophy and cortical alterations in Parkinson's disease with apathy.帕金森病伴淡漠患者的胆碱能基底前脑萎缩及皮质改变。
Parkinsonism Relat Disord. 2025 May;134:107793. doi: 10.1016/j.parkreldis.2025.107793. Epub 2025 Mar 13.
7
Basal forebrain integrity, cholinergic innervation and cognition in idiopathic Parkinson's disease.特发性帕金森病中的基底前脑完整性、胆碱能神经支配与认知
Brain. 2024 May 3;147(5):1799-1808. doi: 10.1093/brain/awad420.
8
In vivo cholinergic basal forebrain degeneration and cognition in Parkinson's disease: Imaging results from the COPPADIS study.帕金森病患者活体胆碱能基底前脑退化与认知:来自 COPPADIS 研究的影像学结果。
Parkinsonism Relat Disord. 2021 Jul;88:68-75. doi: 10.1016/j.parkreldis.2021.05.027. Epub 2021 May 31.
9
Imaging biomarkers of cortical neurodegeneration underlying cognitive impairment in Parkinson's disease.帕金森病认知障碍潜在的皮质神经退行性变的影像学生物标志物。
Eur J Nucl Med Mol Imaging. 2025 May;52(6):2002-2014. doi: 10.1007/s00259-025-07070-z. Epub 2025 Jan 31.
10
Quantitative EEG and cholinergic basal forebrain atrophy in Parkinson's disease and mild cognitive impairment.帕金森病和轻度认知障碍的定量脑电图与胆碱能基底前脑萎缩。
Neurobiol Aging. 2021 Oct;106:37-44. doi: 10.1016/j.neurobiolaging.2021.05.023. Epub 2021 Jun 5.

本文引用的文献

1
Diagnostic Accuracy of a Plasma Phosphorylated Tau 217 Immunoassay for Alzheimer Disease Pathology.血浆磷酸化 Tau 217 免疫测定法对阿尔茨海默病病理学的诊断准确性
JAMA Neurol. 2024 Mar 1;81(3):255-263. doi: 10.1001/jamaneurol.2023.5319.
2
Characteristics of amnestic patients with hypometabolism patterns suggestive of Lewy body pathology.遗忘型患者的特征表现为代谢低下模式,提示路易体病理。
Brain. 2023 Nov 2;146(11):4520-4531. doi: 10.1093/brain/awad194.
3
Synaptic Density and Glucose Consumption in Patients with Lewy Body Diseases: An [ C]UCB-J and [ F]FDG PET Study.
路易体病患者的突触密度和葡萄糖代谢:一项[¹¹C]UCB-J 和 [¹⁸F]FDG PET 研究。
Mov Disord. 2023 May;38(5):796-805. doi: 10.1002/mds.29375. Epub 2023 Mar 11.
4
Distribution of cholinergic nerve terminals in the aged human brain measured with [F]FEOBV PET and its correlation with histological data.用 [F]FEOBV PET 测量老年人大脑胆碱能神经末梢的分布及其与组织学数据的相关性。
Neuroimage. 2023 Apr 1;269:119908. doi: 10.1016/j.neuroimage.2023.119908. Epub 2023 Jan 29.
5
Atrophy of the Cholinergic Basal Forebrain can Detect Presynaptic Cholinergic Loss in Parkinson's Disease.基底前脑胆碱能萎缩可检测帕金森病中的胆碱能节前神经元丢失。
Ann Neurol. 2023 May;93(5):991-998. doi: 10.1002/ana.26596. Epub 2023 Jan 24.
6
Performance of plasma phosphorylated tau 181 and 217 in the community.社区人群中血浆磷酸化 tau181 和 tau217 的检测性能。
Nat Med. 2022 Jul;28(7):1398-1405. doi: 10.1038/s41591-022-01822-2. Epub 2022 May 26.
7
Cholinergic system changes in Parkinson's disease: emerging therapeutic approaches.帕金森病胆碱能系统改变:新兴治疗方法。
Lancet Neurol. 2022 Apr;21(4):381-392. doi: 10.1016/S1474-4422(21)00377-X. Epub 2022 Feb 4.
8
Prevalence Estimates of Amyloid Abnormality Across the Alzheimer Disease Clinical Spectrum.阿尔茨海默病临床谱系中淀粉样蛋白异常的患病率估计
JAMA Neurol. 2022 Mar 1;79(3):228-243. doi: 10.1001/jamaneurol.2021.5216.
9
In vivo cholinergic basal forebrain degeneration and cognition in Parkinson's disease: Imaging results from the COPPADIS study.帕金森病患者活体胆碱能基底前脑退化与认知:来自 COPPADIS 研究的影像学结果。
Parkinsonism Relat Disord. 2021 Jul;88:68-75. doi: 10.1016/j.parkreldis.2021.05.027. Epub 2021 May 31.
10
Dopaminergic and Serotonergic Degeneration and Cortical [ F]Fluorodeoxyglucose Positron Emission Tomography in De Novo Parkinson's Disease.在原发性帕金森病中多巴胺能和血清素能退化与皮质 [ F]氟脱氧葡萄糖正电子发射断层扫描。
Mov Disord. 2021 Oct;36(10):2293-2302. doi: 10.1002/mds.28654. Epub 2021 May 22.